|
|
Ron Rowland: The final numbers are in, and 2011 was officially a “flat” year for the S&P 500. Without dividends, the large-cap stock index was actually down a fraction. With dividends, it gained only 2.1 Read more…
John Nyaradi: Some ETFs are hot and some are not as we enter 2012. A famous stock market axiom says that “a rising tides lifts all boats,” however, in markets like today’s bifurcated environment, vast Read more…
Eric Dutram: The past week was yet another choppy one in the markets as European events continued to dominate headlines. Generally speaking, however, it was a pretty solid period for broad stocks as the S&P 500 added nearly 6% in the time period, helping to reverse much of the recent losses in the Read more…
David Fry: Our goal in this profile is to help investors wade through the many competing ETF offerings available. Using our long experience as an ETF publication, and nearly 40 years in the investment business, we can help select those ETFs that matter and may or may not be repetitive. Read more…
NASDAQ:IBB, NYSE:FBT, NYSE:FXH, NYSE:IHF, NYSE:IYH, NYSE:PPH, NYSE:XBI, NYSE:XLV
Despite ongoing concerns over debt issues in developed markets and inflation fears in emerging nations, a number of equity sectors have managed to post solid returns thanks to increased Read more…
As the year comes to a close, many equity markets are still seeking to reclaim pre-recession levels and the outlook for 2011 is far from certain. Recent weeks have seen renewed worries over the Read more…
Since starting my True Wealth newsletter in 2001, I’ve avoided buying big U.S. stocks. I’ve avoided big-name stocks because I thought they were too expensive. But now, for the first time in my Read more…
A new two in one defibrulator tool for synchronizing heart contractions slowed the progression of heart failure when implanted in patients with few or no symptoms, according to a study that could expand use of the devices. The devices reduced deaths and medical treatments for heart failure by 29 percent compared with standard defibrillators, Boston Scientific, said yesterday in a statement. Read more…
Most Comments